Filing Details
- Accession Number:
- 0001849521-24-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-03 17:30:57
- Reporting Period:
- 2024-05-31
- Accepted Time:
- 2024-06-03 17:30:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Aspira Women's Health Inc. | AWH | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1849521 | Nicole Sandford | C/O Aspira Women'S Health Inc. 12117 Bee Caves Rd Bldg 3-100 Austin TX 78738 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-31 | 9,493 | $2.42 | 70,596 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.34 to $2.45 per share. The reporting person undertakes to provide to AWH, any security holder of AWH or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Billionaire Hedge Funds
